EPIRUBICIN Safety Questions, EPIRUBICIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about EPIRUBICIN. Our extensive database of EPIRUBICIN adverse events and EPIRUBICIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about EPIRUBICIN
EPIRUBICIN Safety Reports
Total EPIRUBICIN reports: 130.EPIRUBICIN FDA safety alerts: 2007 .
Reported deaths: 34 Reported hospitalizations: 58.
Take EPIRUBICIN Side Effects Survey or Share Your EPIRUBICIN Story. Read More Here.
Showing 1-75 of 130 Next >
Health Professional from UNITED KINGDOM reported EPIRUBICIN problem on Sept 25, 2006. Female patient, 64 years of age, weighting 125.4 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, neutrophil count decreased. EPIRUBICIN dosage: 140 MG TOTAL IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADCAL, ZOMETA. Patient died on 08/21/2006.EPIRUBICIN problem was reported by a Health Professional from UNITED KINGDOM on Sept 22, 2006. Female patient, 70 years of age, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: angina pectoris, chest pain. EPIRUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, ASPIRIN, BENDROFLUMETHIAZIDE, FELODIPINE, LACTULOSE. Patient was hospitalized. Patient recovered.
Physician from reported EPIRUBICIN problem on Oct 11, 2006. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: chills, leukopenia, mental disorder, pyrexia, restlessness, tachycardia. EPIRUBICIN dosage: (294 MG, 2 IN 1 WK), INTRAVENOUS. During the same period patient was treated with TAXOL, CYCLOPHOSPHAMIDE, ARANESP, NEULASTA, PLASTULEN N, FORTECORTIN, ZOFRAN, EMEND. Patient was hospitalized. Patient recovered.
EPIRUBICIN problem was reported by a Health Professional from FRANCE on Oct 09, 2006. Female patient, 42 years of age, weighting 105.8 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: cholestasis, cytolytic hepatitis, pain. EPIRUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported EPIRUBICIN problem on Oct 12, 2006. Male patient, 77 years of age, was diagnosed with hepatic neoplasm malignant and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: alveolitis allergic, pleural effusion, pneumonia, procedural complication, vascular anomaly. EPIRUBICIN dosage: 30 MG (1 IN 1 D), INTRA-ARTERIAL. During the same period patient was treated with LIPIODOL ULTRA, DEXTROMETHORPHAN HYDROBROMIDE, MUCODYNE, USRO, LEVOTHYROXINE, BLOPRESS, BASEN, NIKORANMART. Patient was hospitalized. Patient recovered.
EPIRUBICIN problem was reported by a Health Professional from UNITED KINGDOM on Oct 17, 2006. Female patient, 59 years of age, weighting 187.4 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: phlebosclerosis. EPIRUBICIN dosage: unknown. During the same period patient was treated with OMEPRAZOLE, METFORMIN, LIPITOR, ASPIRIN. Patient recovered.
Physician from JAPAN reported EPIRUBICIN problem on Oct 25, 2006. Male patient was diagnosed with hepatic neoplasm and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: hepatic neoplasm malignant recurrent, metastases to bone, metastases to lymph nodes, neuroendocrine carcinoma. EPIRUBICIN dosage: unknown. Patient died on 09/01/2005.
EPIRUBICIN problem was reported by a Physician from JAPAN on Nov 09, 2006. Female patient, 65 years of age, weighting 132.3 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, lymphocyte stimulation test positive. EPIRUBICIN dosage: 110 MG (110 MG, 1 IN 1 D). During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE, PAXIL, DEPROMEL, FLUMEZIN, ARTANE, LORAZEPAM, ARICEPT. Patient was hospitalized and became disabled. Patient recovered.
Physician from GERMANY reported EPIRUBICIN problem on Nov 08, 2006. Female patient, 65 years of age, weighting 242.5 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: erythema, extravasation, impaired healing, infection, necrosis. EPIRUBICIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
EPIRUBICIN problem was reported by a Physician from UNITED KINGDOM on Nov 14, 2006. Female patient, 60 years of age, weighting 224.9 lb, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: bedridden, headache, photopsia. EPIRUBICIN dosage: (200 MG, 1 IN 1 D), INTRAVENOUS. During the same period patient was treated with NEULASTA, SALBUTAMOL, ONDANSETRON. Patient recovered.
Physician from FRANCE reported EPIRUBICIN problem on Nov 23, 2006. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: angiopathy, erythema, petechiae. EPIRUBICIN dosage: 100 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient recovered.
EPIRUBICIN problem was reported by a Physician from JAPAN on Nov 20, 2006. Female patient, 59 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, interstitial lung disease, vasculitis, white blood cell count decreased. EPIRUBICIN dosage: 25 MG MG/M*2 (WEEKLY). During the same period patient was treated with DOCETAXEL. Patient recovered.
Pharmacist from JAPAN reported EPIRUBICIN problem on Nov 28, 2006. Female patient, 60 years of age, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. EPIRUBICIN dosage: 100MG/M. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.
EPIRUBICIN problem was reported by a Physician from JAPAN on Dec 06, 2006. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. EPIRUBICIN dosage: 100 MG/M*2, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.
Health Professional from UNITED KINGDOM reported EPIRUBICIN problem on Dec 15, 2006. Female patient, 47 years of age, weighting 206.8 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: erythema, pain in extremity, tenderness. EPIRUBICIN dosage: unknown. Patient recovered.
EPIRUBICIN problem was reported by a Health Professional from UNITED KINGDOM on Dec 15, 2006. Female patient, 41 years of age, weighting 154.3 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: dyskinesia, pain in extremity. EPIRUBICIN dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported EPIRUBICIN problem on Dec 08, 2006. Female patient, 47 years of age, weighting 206.8 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: erythema, pain in extremity. EPIRUBICIN dosage: 200 MG Q3W IV. Patient recovered.
EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 08, 2006. Female patient, 35 years of age, weighting 215.2 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: limb discomfort. EPIRUBICIN dosage: 200 MG 3/WK IV. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported EPIRUBICIN problem on Dec 08, 2006. Female patient, 41 years of age, weighting 154.3 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: injected limb mobility decreased, pain in extremity. EPIRUBICIN dosage: 180 MG PER_CYCLE IV. Patient recovered.
EPIRUBICIN problem was reported by a Physician from FRANCE on Nov 23, 2006. Female patient, weighting 172.0 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: erythema, petechiae. EPIRUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient recovered.
Pharmacist from JAPAN reported EPIRUBICIN problem on Dec 08, 2006. Female patient was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: vasculitis. EPIRUBICIN dosage: DAILY DOSE:100MG/M*2. During the same period patient was treated with DECADRON, FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.
EPIRUBICIN problem was reported by a Physician from JAPAN on Dec 08, 2006. Female patient was diagnosed with hepatitis c and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: anti-platelet antibody positive, embolism, platelet count decreased. EPIRUBICIN dosage: unknown. During the same period patient was treated with LIPIODOL ULTRA. Patient died.
Health Professional from UNITED KINGDOM reported EPIRUBICIN problem on Dec 15, 2006. Female patient, 36 years of age, weighting 180.8 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: injection site pain, malaise, pain in extremity. EPIRUBICIN dosage: unknown. Patient recovered.
EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 21, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, candida serology positive, febrile neutropenia, fungus sputum test positive, pneumonitis, respiratory failure, streptococcal infection. EPIRUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient died.
Pharmacist from JAPAN reported EPIRUBICIN problem on June 22, 2007. Female patient, 40 years of age, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: angiopathy, pigmentation disorder, vasculitis. EPIRUBICIN dosage: DAILY DOSE:100MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient recovered.
EPIRUBICIN problem was reported by a Pharmacist from JAPAN on June 27, 2007. Female patient, 66 years of age, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: angiopathy, phlebitis, pigmentation disorder. EPIRUBICIN dosage: DAILY DOSE:100MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL. Patient recovered.
Health Professional from GREECE reported EPIRUBICIN problem on June 29, 2007. Male patient, 65 years of age, weighting 143.3 lb, was diagnosed with bladder cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: cystitis interstitial. EPIRUBICIN dosage: unknown. Patient recovered.
EPIRUBICIN problem was reported by a Health Professional from UNITED KINGDOM on July 06, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. EPIRUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, VINCRISTINE, ETOPOSIDE, IFOSFAMIDE, ACTINOMYCIN D. Patient died.
Health Professional from GERMANY reported EPIRUBICIN problem on July 17, 2007. Female patient, 45 years of age, weighting 165.3 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: oesophagitis. EPIRUBICIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 12, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumonitis. EPIRUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.
Consumer or non-health professional from SPAIN reported EPIRUBICIN problem on July 19, 2007. Male patient, weighting 158.7 lb, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: asthenia, neutropenia. EPIRUBICIN dosage: unknown. During the same period patient was treated with OXALIPLATIN, CAPECITABINE, HIPOARTEL. Patient was hospitalized. Patient recovered.
EPIRUBICIN problem was reported by a Consumer or non-health professional from ITALY on July 24, 2007. Female patient, 50 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. EPIRUBICIN dosage: DAILY DOSE:75MG/M*2. During the same period patient was treated with DOCETAXEL, NEUPOGEN. Patient died on 07/15/2007.
Consumer or non-health professional from UNITED KINGDOM reported EPIRUBICIN problem on July 20, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure. EPIRUBICIN dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.
EPIRUBICIN problem was reported by a Health Professional from GREECE on July 24, 2007. Male patient, 65 years of age, weighting 143.3 lb, was diagnosed with bladder cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: cystitis interstitial. EPIRUBICIN dosage: unknown. Patient recovered.
Consumer or non-health professional from ITALY reported EPIRUBICIN problem on July 24, 2007. Female patient, 50 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN. EPIRUBICIN dosage: DAILY DOSE:75MG/M*2. During the same period patient was treated with DOCETAXEL, NEUPOGEN. Patient died on 07/15/2007.
EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 24, 2007. Female patient, child 6 years of age, was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: beta haemolytic streptococcal infection, blood culture positive, candidiasis, febrile neutropenia, mucosal inflammation, pneumonitis. EPIRUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE. Patient was hospitalized. Patient died.
Health Professional from UNITED STATES reported EPIRUBICIN problem on July 26, 2007. Male patient, 74 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: anaemia, bone marrow failure, rash pruritic, thrombocytopenia, white blood cell count decreased. EPIRUBICIN dosage: unknown. During the same period patient was treated with METHOTREXATE, MITOMYCIN, ETOPOSIDE, FLUOROURACIL, PROLEUKIN, LEUCOVORIN CALCIUM. Patient recovered.
EPIRUBICIN problem was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Female patient, 38 years of age, weighting 149.0 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, jugular vein thrombosis. EPIRUBICIN dosage: 149MG Q3WK IV BOLUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported EPIRUBICIN problem on Aug 01, 2007. Female patient, 59 years of age, was diagnosed with bladder cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: anorexia, fatigue, hepatitis b. EPIRUBICIN dosage: unknown. During the same period patient was treated with CISPLATIN, METHOTREXATE. Patient recovered.
EPIRUBICIN problem was reported by a Physician from JAPAN on Aug 03, 2007. Male patient, weighting 169.8 lb, was diagnosed with bladder neoplasm and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: toxic skin eruption. EPIRUBICIN dosage: unknown. During the same period patient was treated with PANSPORIN, ADONA, TRANSAMIN. Patient recovered.
Consumer or non-health professional from JAPAN reported EPIRUBICIN problem on Aug 09, 2007. Female patient, 59 years of age, was diagnosed with bladder cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: anorexia, fatigue, hepatitis b. EPIRUBICIN dosage: unknown. During the same period patient was treated with CISPLATIN, METHOTREXATE, DEXAMETHASONE. Patient recovered.
EPIRUBICIN problem was reported by a Health Professional from FRANCE on Aug 07, 2007. Female patient was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia, neoplasm malignant. EPIRUBICIN dosage: DAILY DOSE:85MG-FREQ:CYCLIC. During the same period patient was treated with FLUOROURACIL, ENDOXAN, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.
Physician from FINLAND reported EPIRUBICIN problem on Aug 06, 2007. Female patient, 35 years of age, was diagnosed with malignant histiocytosis and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: acute promyelocytic leukaemia. EPIRUBICIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient died.
EPIRUBICIN problem was reported by a Physician from JAPAN on Aug 09, 2007. Female patient, weighting 97.00 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, sepsis. EPIRUBICIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, ENDOXAN. Patient was hospitalized. Patient died on 07/25/2007.
Consumer or non-health professional from NETHERLANDS reported EPIRUBICIN problem on Aug 13, 2007. Female patient, weighting 136.7 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: breast cancer. EPIRUBICIN dosage: unknown. During the same period patient was treated with DOCETAXEL, TAMOXIFEN CITRATE. Patient recovered.
EPIRUBICIN problem was reported by a Health Professional from UNITED STATES on Aug 24, 2007. Female patient, 58 years of age, weighting 130.0 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: asthma, chronic obstructive pulmonary disease, dyspnoea, neutropenia. EPIRUBICIN dosage: 90 MG/M2 Q3WK X 4 IV BOLUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported EPIRUBICIN problem on Aug 21, 2007. Female patient, weighting 97.00 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, neutropenia, sepsis. EPIRUBICIN dosage: unknown. During the same period patient was treated with ENDOXAN. Patient was hospitalized. Patient died on 07/25/2007.
EPIRUBICIN problem was reported by a Physician from JAPAN on Aug 23, 2007. Male patient, weighting 169.8 lb, was diagnosed with bladder neoplasm and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: toxic skin eruption. EPIRUBICIN dosage: unknown. During the same period patient was treated with PANSPORIN, ADONA, TRANSAMIN. Patient recovered.
Consumer or non-health professional from NETHERLANDS reported EPIRUBICIN problem on Aug 24, 2007. Female patient, weighting 136.7 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: breast cancer. EPIRUBICIN dosage: DAILY DOSE:80MG. During the same period patient was treated with DOCETAXEL, TAMOXIFEN CITRATE. Patient recovered.
EPIRUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 29, 2007. Female patient, weighting 191.8 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, dysphasia, odynophagia. EPIRUBICIN dosage: unknown. During the same period patient was treated with DOCETAXEL, ENOXAPARIN, AUGMENTIN, DEXAMETHASONE, CITALOPRAM HYDROBROMIDE. Patient died on 03/10/2007.
Physician from GERMANY reported EPIRUBICIN problem on Aug 31, 2007. Male patient was diagnosed with hepatic neoplasm malignant and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, hypertensive crisis. EPIRUBICIN dosage: DAILY DOSE:50MG. Patient was hospitalized. Patient recovered.
EPIRUBICIN problem was reported by a Pharmacist from GERMANY on Aug 31, 2007. Male patient was diagnosed with hepatic neoplasm malignant and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: hypertensive crisis, nausea. EPIRUBICIN dosage: DAILY DOSE:40MG. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported EPIRUBICIN problem on Sept 11, 2007. Male patient, weighting 220.0 lb, was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood magnesium decreased, blood potassium decreased, blood pressure decreased, dizziness, dyspnoea, syncope. EPIRUBICIN dosage: 80 MG. Patient was hospitalized. Patient recovered.
EPIRUBICIN problem was reported by a Physician from GREECE on Sept 14, 2007. Female patient was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, sepsis. EPIRUBICIN dosage: DAILY DOSE:187MG. During the same period patient was treated with EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, METHOTREXATE. Patient died on 09/03/2007.
Health Professional from UNITED STATES reported EPIRUBICIN problem on Sept 26, 2007. Female patient, 38 years of age, weighting 149.0 lb, was diagnosed with breast cancer and was treated with EPIRUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, jugular vein thrombosis, staphylococcal infection, subclavian vein thrombosis. EPIRUBICIN dosage: 149MG IV Q3WK. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Showing 1-75 of 130 Next >